I'd like to take the job http://ghettotube.in.net/ gettotube The U.S. Food and Drug Administration in late 2011 withdrewits approval of Avastin for breast cancer, three years afterclearing it for the condition. Subsequent research showed thedrug was not effective enough to justify its risks, even thoughsome women had strong responses to the medicine.